{"id":"https://openalex.org/W4416637716","doi":"https://doi.org/10.1183/13993003.congress-2025.oa1189","title":"ETH47 is a novel mRNA drug candidate for the prevention of asthma exacerbations","display_name":"ETH47 is a novel mRNA drug candidate for the prevention of asthma exacerbations","publication_year":2025,"publication_date":"2025-09-27","ids":{"openalex":"https://openalex.org/W4416637716","doi":"https://doi.org/10.1183/13993003.congress-2025.oa1189"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2025.oa1189","doi":"https://doi.org/10.1183/13993003.congress-2025.oa1189","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.oa1189","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105098610","display_name":"Thomas Langenickel","orcid":"https://orcid.org/0009-0000-6891-1968","observed_orcids":["https://orcid.org/0009-0000-6891-1968"]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Thomas Langenickel","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012879826","display_name":"Nigel Tomkinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Nigel Tomkinson","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120426769","display_name":"Julia Strohwasser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Julia Strohwasser","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071127941","display_name":"Marija Marolt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Marija Marolt","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120664447","display_name":"Julia Nennstiel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Julia Nennstiel","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120472502","display_name":"Constanze List","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Constanze List","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christian Dohmen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christian Dohmen","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120613360","display_name":"Claudia Wilfers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Claudia Wilfers","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120426770","display_name":"Michaela Koburg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Michaela Koburg","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092937481","display_name":"Katharina Sohr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Katharina Sohr","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113305883","display_name":"Steffen Meyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Steffen Meyer","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105098609","display_name":"Eva Lichtenegger-Hartl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Eva Lichtenegger-Hartl","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105098608","display_name":"Anna Macht","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Anna Macht","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087196577","display_name":"Elisa Murenu","orcid":"https://orcid.org/0000-0003-0209-5448","observed_orcids":["https://orcid.org/0000-0003-0209-5448"]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Elisa Murenu","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120613359","display_name":"Elisabeth Wilkowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Elisabeth Wilkowski","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075406960","display_name":"Elke Tatjana Aristizabal Prada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Elke Tatjana Aristizabal-Prada","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015077988","display_name":"Christian Plank","orcid":"https://orcid.org/0000-0002-6072-4903","observed_orcids":["https://orcid.org/0000-0002-6072-4903"]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christian Plank","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103520144","display_name":"Carsten Rudolph","orcid":"https://orcid.org/0000-0001-9050-5675","observed_orcids":["https://orcid.org/0000-0001-9050-5675"]},"institutions":[{"id":"https://openalex.org/I4210160276","display_name":"Ethris (Germany)","ror":"https://ror.org/05mz52w65","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210160276"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Carsten Rudolph","raw_affiliation_strings":["1Ethris GmbH, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ethris GmbH, Planegg, Germany","institution_ids":["https://openalex.org/I4210160276"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210160276"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"OA1189","last_page":"OA1189"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.6377000212669373,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.6377000212669373,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.14259999990463257,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.09489999711513519,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mrna-vaccines","display_name":"mRNA vaccines","score":0.6309999823570251},{"id":"https://openalex.org/keywords/interferon-lambda","display_name":"interferon lambda","score":0.9810000061988831},{"id":"https://openalex.org/keywords/asthma-exacerbations","display_name":"asthma exacerbations","score":0.9459999799728394},{"id":"https://openalex.org/keywords/intranasal-drug-delivery","display_name":"intranasal drug delivery","score":0.6940000057220459},{"id":"https://openalex.org/keywords/mrna-therapeutics","display_name":"mRNA therapeutics","score":0.46700000762939453},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7519999742507935},{"id":"https://openalex.org/keywords/target-engagement","display_name":"target engagement","score":0.6850000023841858},{"id":"https://openalex.org/keywords/interferon-stimulated-genes","display_name":"interferon-stimulated genes","score":0.9070000052452087},{"id":"https://openalex.org/keywords/lipid-nanoparticles","display_name":"lipid nanoparticles","score":0.5730000138282776},{"id":"https://openalex.org/keywords/viral-triggers-of-asthma","display_name":"viral triggers of asthma","score":0.578000009059906}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8910999894142151},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6796000003814697},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.6621999740600586},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6312999725341797},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.4876999855041504},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4593999981880188},{"id":"https://openalex.org/C85663871","wikidata":"https://www.wikidata.org/wiki/Q6966562","display_name":"Nasal administration","level":2,"score":0.4584999978542328},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42829999327659607},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4050999879837036},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3727000057697296},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.3652999997138977},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3497999906539917},{"id":"https://openalex.org/C2909082789","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma exacerbations","level":3,"score":0.34380000829696655},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.34299999475479126},{"id":"https://openalex.org/C2909814679","wikidata":"https://www.wikidata.org/wiki/Q1425813","display_name":"Nasal Lavage","level":3,"score":0.326200008392334},{"id":"https://openalex.org/C2776954882","wikidata":"https://www.wikidata.org/wiki/Q840343","display_name":"Inhalation","level":2,"score":0.3248000144958496},{"id":"https://openalex.org/C59377437","wikidata":"https://www.wikidata.org/wiki/Q515471","display_name":"Mucous membrane of nose","level":2,"score":0.3237999975681305},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3212999999523163},{"id":"https://openalex.org/C2781293274","wikidata":"https://www.wikidata.org/wiki/Q5376560","display_name":"Endotype","level":3,"score":0.3122999966144562},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2971999943256378},{"id":"https://openalex.org/C207480886","wikidata":"https://www.wikidata.org/wiki/Q42982","display_name":"Allergy","level":2,"score":0.26649999618530273},{"id":"https://openalex.org/C2777844070","wikidata":"https://www.wikidata.org/wiki/Q3245488","display_name":"Nasal congestion","level":3,"score":0.2540999948978424}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2025.oa1189","doi":"https://doi.org/10.1183/13993003.congress-2025.oa1189","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.oa1189","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4416636793","https://openalex.org/W1908110721","https://openalex.org/W4283829238","https://openalex.org/W2922278914","https://openalex.org/W2053874484","https://openalex.org/W4293335008","https://openalex.org/W2016160459","https://openalex.org/W2150961146","https://openalex.org/W3094592496","https://openalex.org/W2045988658"],"abstract_inverted_index":{"Introduction:":[0],"Virus":[1],"infections":[2],"are":[3],"the":[4,152],"main":[5],"trigger":[6],"of":[7,41,45,90,115,151,161,175,217,236,242],"asthma":[8,243],"exacerbations.":[9,244],"Interferon":[10],"(INF)":[11],"\u03bb,":[12],"critical":[13],"for":[14],"anti-viral":[15],"innate":[16],"immunity,":[17],"is":[18,23],"dysregulated":[19],"in":[20,47,108,119,149,168,197,201,228],"asthmatics.":[21],"ETH47":[22,46,58,125,218,237],"a":[24,239],"novel,":[25],"nasally":[26],"delivered":[27],"mRNA":[28],"therapeutic":[29],"encoding":[30],"INF\u03bb.":[31],"Objective:":[32],"To":[33],"investigate":[34],"safety,":[35],"tolerability,":[36],"biodistribution":[37],"and":[38,82,93,113,136,178,180,184,206,223],"target":[39,212,226],"engagement":[40,101,227],"single":[42],"nasal":[43,109,120,202],"doses":[44,174],"humans.":[48,229],"Methods:":[49],"40":[50],"healthy":[51],"participants":[52],"were":[53,95,131,137,142],"randomized":[54],"3:1":[55],"to":[56,97,208],"receive":[57],"or":[59,147,164],"placebo":[60,148],"across":[61,210],"5":[62],"dose":[63,172],"levels":[64,107,196],"(7.2,":[65],"36,":[66],"175,":[67],"700,":[68],"1400":[69],"\u00b5g).":[70],"Safety":[71],"endpoints":[72],"included":[73],"adverse":[74],"events":[75],"(AEs),":[76],"vital":[77],"signs,":[78],"physical":[79],"examinations,":[80],"ECGs,":[81],"safety":[83],"laboratory":[84],"measurements,":[85],"including":[86],"cytokines.":[87],"Serum":[88],"concentrations":[89,167],"mRNA,":[91,163],"LNP":[92],"INF\u03bb":[94,106,166],"measured":[96],"determine":[98],"bioavailability.":[99],"Target":[100],"was":[102,126,156,219],"assessed":[103],"by":[104],"measuring":[105],"lining":[110],"fluid":[111],"(NLF)":[112],"expression":[114,200],"interferon-stimulated":[116],"genes":[117],"(ISGs)":[118],"brush":[121],"samples.":[122],"Results:":[123],"Nasal":[124,215],"well":[127,221],"tolerated.":[128],"Most":[129],"AEs":[130],"mild,":[132],"resolved":[133],"without":[134],"treatment":[135],"not":[138],"considered":[139],"drug-related.":[140],"There":[141,155],"no":[143,157],"changes":[144],"from":[145],"baseline":[146],"any":[150],"safety-related":[153],"endpoints.":[154],"relevant":[158,211],"systemic":[159],"bioavailability":[160],"INF\u03bb,":[162],"LNP.":[165],"NLF":[169],"increased":[170,194,204],"with":[171,193],"at":[173,187],"36":[176],"\u00b5g":[177],"higher":[179],"ranged":[181],"between":[182],"261":[183],"4,542":[185],"pg/mL":[186],"6":[188],"hours":[189],"after":[190],"dosing.":[191],"Consistent":[192],"INF":[195],"NLF,":[198],"ISG":[199],"brushes":[203],"dose-dependently":[205],"up":[207],"11-fold":[209],"genes.":[213],"Conclusions:":[214],"administration":[216],"safe,":[220],"tolerated":[222],"demonstrated":[224],"dose-dependent":[225],"Trial":[230],"results":[231],"support":[232],"further":[233],"clinical":[234],"development":[235],"as":[238],"novel":[240],"preventer":[241]},"counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-11-25T00:00:00"}